Absence of JAK2 V617F mutation in thalassemia intermedia patients

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text

Life Sciences, Genetics, Hematology +15

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 3.4K citations

Life Sciences, Genetics, Hematology +14

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

Bruce A. Witthuhn, Frederick W. Quelle, Olli Silvennoinen et al. · Cell · 1993 · 1.2K citations

Life Sciences, Biochemistry, Molecular Biology +6

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Amy V. Jones · Blood · 2005 · 843 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Expression cloning of the murine erythropoietin receptor

Alan D. D’Andrea, H F Lodish, Gordon Wong · Cell · 1989 · 769 citations

Life Sciences, Endocrinology, Molecular Biology +7